Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 12692540)

1.

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST.

Nat Med. 2003 May;9(5):533-9. Epub 2003 Apr 14.

PMID:
12692540
2.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
3.

ESAT-6 proteins: protective antigens and virulence factors?

Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R.

Trends Microbiol. 2004 Nov;12(11):500-8. Review.

PMID:
15488391
4.

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.

Ganguly N, Siddiqui I, Sharma P.

Tuberculosis (Edinb). 2008 Nov;88(6):510-7. doi: 10.1016/j.tube.2008.05.002. Epub 2008 Jul 21. Review.

PMID:
18640874
5.

Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.

Dietrich G, Viret JF, Hess J.

Int J Med Microbiol. 2003 Feb;292(7-8):441-51. Review.

PMID:
12635927
6.

Live antigen carriers as tools for improved anti-tuberculosis vaccines.

Hess J, Kaufmann SH.

FEMS Immunol Med Microbiol. 1999 Feb;23(2):165-73. Review.

7.

Prospects for new vaccines against tuberculosis.

Brandt L, Orme I.

Biotechniques. 2002 Nov;33(5):1098, 1100, 1102. Review. No abstract available.

PMID:
12449388
8.

Antigen discovery and tuberculosis vaccine development in the post-genomic era.

Louise R, Skjøt V, Agger EM, Andersen P.

Scand J Infect Dis. 2001;33(9):643-7. Review.

PMID:
11669220
9.

Leprosy and tuberculosis vaccine design.

Kaufmann SH.

Trop Med Parasitol. 1989 Sep;40(3):251-7. Review.

PMID:
2482532
10.

Mycobacterial proteins--immune targets for antituberculous subunit vaccine.

Dhiman N, Khuller GK.

Indian J Exp Biol. 1999 Dec;37(12):1157-66. Review.

PMID:
10865880
11.

The T cell response to secreted antigens of Mycobacterium tuberculosis.

Andersen P.

Immunobiology. 1994 Oct;191(4-5):537-47. Review.

PMID:
7713568
12.

BCG-induced mucosal immune responses.

Gheorghiu M.

Int J Immunopharmacol. 1994 May-Jun;16(5-6):435-44. Review.

PMID:
7927990
13.

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.

Dietrich G, Viret JF, Hess J.

Vaccine. 2003 Jan 30;21(7-8):667-70. Review.

PMID:
12531337
14.

TB vaccines: progress and problems.

Andersen P.

Trends Immunol. 2001 Mar;22(3):160-8. Review.

PMID:
11286732
15.

Early secretory antigenic target-6 of Mycobacterium tuberculosis: enigmatic factor in pathogen-host interactions.

Chandra Rai R, Dwivedi VP, Chatterjee S, Raghava Prasad DV, Das G.

Microbes Infect. 2012 Nov;14(13):1220-6. doi: 10.1016/j.micinf.2012.07.019. Epub 2012 Aug 9. Review.

PMID:
22909901
16.

The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis.

Krishnan N, Robertson BD, Thwaites G.

Tuberculosis (Edinb). 2010 Nov;90(6):361-6. doi: 10.1016/j.tube.2010.08.005. Epub 2010 Sep 9. Review.

PMID:
20829117
17.

[The antigenic and immunogenic substances in mycobacteria and the problem of creating a molecular vaccine].

Vorob'ev AA, Badukshanova NM, Fadeeva NI.

Zh Mikrobiol Epidemiol Immunobiol. 1989 Dec;(12):87-93. Review. Russian. No abstract available.

PMID:
2516948
18.

[The application of recombinant Bacillus Calmette-Guérin vaccine and its vector in infectious disease].

Zulpiya T, Ding J.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Oct;30(5):1136-40. Review. Chinese.

PMID:
24459985
19.

Disease model: pulmonary tuberculosis.

McMurray DN.

Trends Mol Med. 2001 Mar;7(3):135-7. Review.

PMID:
11286786
20.

New strategies against an old plague: genetically engineered tuberculosis vaccines.

Dreher D, Kok M, Pechère JC, Nicod LP.

Schweiz Med Wochenschr. 2000 Dec 16;130(50):1925-9. Review.

PMID:
11189437
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk